Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009) The Task Force on the Prevention, Diagnosis, and Treatment of …

…, G Habib, B Hoen… - European heart …, 2009 - academic.oup.com
The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

…, D Haring, JE Harrison, R Havmoeller, RJ Hay, B Hoen… - The lancet, 2012 - thelancet.com
Background Reliable and timely information on the leading causes of death in populations,
and how these are changing, is a crucial input into health policy debates. In the Global …

Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis–Prospective Cohort Study

DR Murdoch, GR Corey, B Hoen, JM Miró… - Archives of internal …, 2009 - jamanetwork.com
Background We sought to provide a contemporary picture of the presentation, etiology, and
outcome of infective endocarditis (IE) in a large patient cohort from multiple locations …

Staphylococcus aureus endocarditis: a consequence of medical progress

VG Fowler, JM Miro, B Hoen, CH Cabell, E Abrutyn… - Jama, 2005 - jamanetwork.com
ContextThe global significance of infective endocarditis (IE) caused by Staphylococcus
aureus is unknown.ObjectivesTo document the international emergence of health care–…

Changing profile of infective endocarditis: results of a 1-year survey in France

B Hoen, F Alla, C Selton-Suty, I Béguinot, A Bouvet… - Jama, 2002 - jamanetwork.com
ContextSince the first modern clinical description of infective endocarditis (IE) at the end of
the 19th century, the profile of the disease has evolved continuously, as highlighted in …

Preeminence of Staphylococcus aureus in Infective Endocarditis: A 1-Year Population-Based Survey

…, F Delahaye, F Alla, X Duval, B Hoen - Clinical infectious …, 2012 - academic.oup.com
Background. Observational studies showed that the profile of infective endocarditis (IE)
significantly changed over the past decades. However, most studies involved referral centers. We …

[HTML][HTML] Hydroxychloroquine use against SARS-CoV-2 infection in non-human primates

…, A Brisebarre, F Touret, C Chapon, B Hoen… - Nature, 2020 - nature.com
Coronavirus disease 2019 (COVID-19) has rapidly become a global pandemic and no antiviral
drug or vaccine is yet available for the treatment of this disease 1 , 2 – 3 . Several clinical …

EPIBACDIAL: a multicenter prospective study of risk factors for bacteremia in chronic hemodialysis patients.

B Hoen, A Paul-Dauphin, D Hestin… - Journal of the American …, 1998 - journals.lww.com
Bacteremic infections are a major cause of mortality and morbidity in chronic hemodialysis
patients. New developments in managing these patients (erythropoietin therapy, nasal …

Challenges in infective endocarditis

TJ Cahill, LM Baddour, G Habib, B Hoen… - Journal of the american …, 2017 - jacc.org
Infective endocarditis is defined by a focus of infection within the heart and is a feared disease
across the field of cardiology. It is frequently acquired in the health care setting, and more …

A prospective, multicenter, randomized trial comparing steroids and pulse cyclophosphamide versus steroids and oral cyclophosphamide in the treatment of …

…, A Dubois, E Hachulla, B Hoen… - … : Official Journal of …, 1997 - Wiley Online Library
Objective. To investigate the effectiveness and side effects of oral versus pulse cyclophosphamide
(CYC) in combination with corticosteroids (CS) in the treatment of systemic Wegener's …